ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Austin, TX, USA:

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer. (BRIA-ABC)

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Interferon infiltration of the inoculation site

Phase 3

BriaCell Therapeutics

New Braunfels, Texas, United States and 35 other locations

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Austin, Texas, United States and 62 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...

Invitation-only
Breast Cancer
Drug: Exemestane Tablets
Drug: Anastrozole Tablets

Phase 3

Tolmar Pharmaceuticals

New Braunfels, Texas, United States and 17 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Trastuzumab deruxtecan
Drug: Capecitabine

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 294 other locations

treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and arom...

Enrolling
Breast Cancer
Drug: Alpelisib
Drug: Fulvestrant

Phase 3

Celcuity

Austin, Texas, United States and 217 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer. The study will also aim to assess the safety of TOL2 ...

Enrolling
Breast Cancer
Drug: Anastrozole Tablets
Drug: Tamoxifen

Phase 3

Tolmar Pharmaceuticals

Austin, Texas, United States and 69 other locations

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

Active, not recruiting
Breast Cancer
Other: Placebo
Drug: Letrozole

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Austin, Texas, United States and 805 other locations

Locations recently updated

doctor's choice of treatment in people with advanced or metastatic breast cancer. Advanced cancer is the one that is unlik...

Enrolling
Advanced or Metastatic Breast Cancer
Drug: Everolimus
Drug: Fulvestrant

Phase 3

Pfizer
Pfizer

Round Rock, Texas, United States and 240 other locations

receptor-low/HER2-negative breast cancer....

Enrolling
Breast Cancer
Drug: Epirubicin
Drug: Olaparib

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 351 other locations

adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurren...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Exemestane
Drug: Letrozole

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 734 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems